Literature DB >> 20667650

N-Acetylcysteine interacts with copper to generate hydrogen peroxide and selectively induce cancer cell death.

Jie Zheng1, Jessica R Lou, Xiao-Xi Zhang, Doris M Benbrook, Marie H Hanigan, Stuart E Lind, Wei-Qun Ding.   

Abstract

A variety of metal-binding compounds have been found to exert anti-cancer activity. We postulated that N-acetylcysteine (NAC), which is a membrane-permeable metal-binding compound, might have anti-cancer activity in the presence of metals. We found that NAC/Cu(II) significantly alters growth and induces apoptosis in human cancer lines, yet NAC/Zn(II) and NAC/Fe(III) do not. We further confirmed that this cytotoxicity of NAC/Cu(II) is attributed to reactive oxygen species (ROS). These findings indicate that the combination of Cu(II) and thiols generates cytotoxic ROS that induce apoptosis in cancer cells. They also indicate a fourth class of anti-neoplastic metal-binding compounds, the "ROS generators".
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20667650      PMCID: PMC3881362          DOI: 10.1016/j.canlet.2010.07.003

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  39 in total

1.  Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study.

Authors:  G J Brewer; R D Dick; D K Grover; V LeClaire; M Tseng; M Wicha; K Pienta; B G Redman; T Jahan; V K Sondak; M Strawderman; G LeCarpentier; S D Merajver
Journal:  Clin Cancer Res       Date:  2000-01       Impact factor: 12.531

2.  Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10.

Authors:  H D Soule; T M Maloney; S R Wolman; W D Peterson; R Brenz; C M McGrath; J Russo; R J Pauley; R F Jones; S C Brooks
Journal:  Cancer Res       Date:  1990-09-15       Impact factor: 12.701

3.  Metal ion chaperone function of the soluble Cu(I) receptor Atx1.

Authors:  R A Pufahl; C P Singer; K L Peariso; S J Lin; P J Schmidt; C J Fahrni; V C Culotta; J E Penner-Hahn; T V O'Halloran
Journal:  Science       Date:  1997-10-31       Impact factor: 47.728

4.  Supplementation with vitamin C and N-acetyl-cysteine increases oxidative stress in humans after an acute muscle injury induced by eccentric exercise.

Authors:  A Childs; C Jacobs; T Kaminski; B Halliwell; C Leeuwenburgh
Journal:  Free Radic Biol Med       Date:  2001-09-15       Impact factor: 7.376

5.  Oxidative inactivation of plasmin and other serine proteases by copper and ascorbate.

Authors:  S E Lind; J R McDonagh; C J Smith
Journal:  Blood       Date:  1993-09-01       Impact factor: 22.113

6.  The toxicity of N-acetylcysteine in laboratory animals.

Authors:  R E Johnston; H C Hawkins; J H Weikel
Journal:  Semin Oncol       Date:  1983-03       Impact factor: 4.929

7.  Pegylated zinc protoporphyrin: a water-soluble heme oxygenase inhibitor with tumor-targeting capacity.

Authors:  S K Sahoo; T Sawa; J Fang; S Tanaka; Y Miyamoto; T Akaike; H Maeda
Journal:  Bioconjug Chem       Date:  2002 Sep-Oct       Impact factor: 4.774

8.  Extracellular glutathione is a source of cysteine for cells that express gamma-glutamyl transpeptidase.

Authors:  M H Hanigan; W A Ricketts
Journal:  Biochemistry       Date:  1993-06-22       Impact factor: 3.162

Review 9.  ROS stress in cancer cells and therapeutic implications.

Authors:  Helene Pelicano; Dennis Carney; Peng Huang
Journal:  Drug Resist Updat       Date:  2004-04       Impact factor: 18.500

Review 10.  N-acetylcysteine and neurodegenerative diseases: basic and clinical pharmacology.

Authors:  Motoki Arakawa; Yoshihisa Ito
Journal:  Cerebellum       Date:  2007-01-19       Impact factor: 3.847

View more
  19 in total

1.  Trolox enhances curcumin's cytotoxicity through induction of oxidative stress.

Authors:  Jie Zheng; Kelsey Payne; Jori E Taggart; Hongchao Jiang; Stuart E Lind; Wei-Qun Ding
Journal:  Cell Physiol Biochem       Date:  2012-04-03

2.  Nitroxoline (8-hydroxy-5-nitroquinoline) is more a potent anti-cancer agent than clioquinol (5-chloro-7-iodo-8-quinoline).

Authors:  Hongchao Jiang; Jori E Taggart; Xiaoxi Zhang; Doris M Benbrook; Stuart E Lind; Wei-Qun Ding
Journal:  Cancer Lett       Date:  2011-07-06       Impact factor: 8.679

3.  Increased generation of intracellular reactive oxygen species initiates selective cytotoxicity against the MCF-7 cell line resultant from redox active combination therapy using copper-thiosemicarbazone complexes.

Authors:  Fady N Akladios; Scott D Andrew; Christopher J Parkinson
Journal:  J Biol Inorg Chem       Date:  2016-03-07       Impact factor: 3.358

4.  Zinc at sub-cytotoxic concentrations induces heme oxygenase-1 expression in human cancer cells.

Authors:  Jing Xue; Shuai Wang; Jinchang Wu; Bethany N Hannafon; Wei-Qun Ding
Journal:  Cell Physiol Biochem       Date:  2013-07-12

5.  Induced Cell Death as a Possible Pathway of Antimutagenic Action.

Authors:  N V Eremina; A K Zhanataev; A D Durnev
Journal:  Bull Exp Biol Med       Date:  2021-05-29       Impact factor: 0.804

6.  Bromelain and N-acetylcysteine inhibit proliferation and survival of gastrointestinal cancer cells in vitro: significance of combination therapy.

Authors:  Afshin Amini; Samar Masoumi-Moghaddam; Anahid Ehteda; David Lawson Morris
Journal:  J Exp Clin Cancer Res       Date:  2014-11-12

7.  Mechanistic characterization of a copper containing thiosemicarbazone with potent antitumor activity.

Authors:  Henning Karlsson; Mårten Fryknäs; Sara Strese; Joachim Gullbo; Gunnar Westman; Ulf Bremberg; Tobias Sjöblom; Tatjana Pandzic; Rolf Larsson; Peter Nygren
Journal:  Oncotarget       Date:  2017-05-02

8.  Targeting 3-phosphoinositide-dependent protein kinase 1 by N-acetyl-cysteine through activation of peroxisome proliferators activated receptor alpha in human lung cancer cells, the role of p53 and p65.

Authors:  Swei Sunny Hann; Fang Zheng; Shunyu Zhao
Journal:  J Exp Clin Cancer Res       Date:  2013-07-18

9.  Development of a copper-clioquinol formulation suitable for intravenous use.

Authors:  Moe Wehbe; Armaan K Malhotra; Malathi Anantha; Cody Lo; Wieslawa H Dragowska; Nancy Dos Santos; Marcel B Bally
Journal:  Drug Deliv Transl Res       Date:  2018-02       Impact factor: 4.617

10.  Cu2+ selective chelators relieve copper-induced oxidative stress in vivo.

Authors:  Ananya Rakshit; Kaustav Khatua; Vinit Shanbhag; Peter Comba; Ankona Datta
Journal:  Chem Sci       Date:  2018-10-02       Impact factor: 9.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.